Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11622933 Soluble estradiol capsule for vaginal insertion

Patent 11622933 was granted and assigned to TherapeuticsMD on April, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
TherapeuticsMD
TherapeuticsMD
0
Date Filed
January 27, 2020
0
Date of Patent
April 11, 2023
0
Patent Applicant
TherapeuticsMD
TherapeuticsMD
0
Patent Application Number
16773903
0
Patent Citations
‌
US Patent 10258630 Vaginal inserted estradiol pharmaceutical compositions and methods
0
‌
US Patent 10052386 Progesterone formulations
0
‌
US Patent 10098894 Transdermal cream
‌
US Patent 10206932 Natural combination hormone replacement formulations and therapies
0
‌
US Patent 11103516 Natural combination hormone replacement formulations and therapies
0
‌
US Patent 11110099 Natural combination hormone replacement formulations and therapies
0
‌
US Patent 11116717 Soluble estradiol capsule for vaginal insertion
0
‌
US Patent 11123283 Soluble estradiol capsule for vaginal insertion
‌
US Patent 11166963 Natural combination hormone replacement formulations and therapies
0
‌
US Patent 11241445 Vaginal inserted estradiol pharmaceutical compositions and methods
0
•••
Patent Inventor Names
Brian A. Bernick
0
Neda Irani
0
Peter H. R. Persicaner
0
Thorsteinn Thorsteinsson
0
Julia M. Amadio
0
Janice Louise Cacace
0
Frederick D. Sancilio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11622933
0
Patent Primary Examiner
‌
Mark V Stevens
0
CPC Code
‌
A61K 9/48
0

Find more entities like US Patent 11622933 Soluble estradiol capsule for vaginal insertion

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.